The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating antitumor activity and response determinants to trastuzumab deruxtecan in pediatric solid tumors.
 
Chelsey Burke
No Relationships to Disclose
 
Diego Ferreira Ferreira Coutinho
No Relationships to Disclose
 
Glorymar Ibanez
No Relationships to Disclose
 
Daoqi You
Employment - Regeneron (I)
Stock and Other Ownership Interests - Regeneron (I)
 
Andoyo A Ndengu
No Relationships to Disclose
 
Paul Calder
No Relationships to Disclose
 
Kristina Guillan
No Relationships to Disclose
 
Armaan Siddiquee
No Relationships to Disclose
 
Nestor Rosales
No Relationships to Disclose
 
Matthew Long
No Relationships to Disclose
 
Raina Fishkin
No Relationships to Disclose
 
Samantha Brosius
No Relationships to Disclose
 
Tamar Y Feinberg
Employment - Volastra Therapeutics
 
Emily K Slotkin
Consulting or Advisory Role - Guidepoint Global; Inhibrx
Research Funding - Esperas Pharma; Lilly (Inst); Lilly (Inst)
 
Michael Vincent Ortiz
Consulting or Advisory Role - Guidepoint Global
Research Funding - Amgen (Inst)
 
Andrew Kung
Leadership - Isabl Technologies
Stock and Other Ownership Interests - Imago Pharma; Isabl Technologies
Consulting or Advisory Role - DarwinHealth; Emendo; Imago Pharma; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing and royalty from bioluminescence imaging models
 
Filemon S Dela Cruz
Research Funding - Eisai; Y-mAbs Therapeutics